Form 4: Sera Prognostics Director Joshua Phillips Reports Share Distributions from Venture Capital Funds

Director Joshua Phillips reports distributions of Sera Prognostics shares from various Catalyst Health Ventures funds to their respective limited partners.

Summary

• Joshua Phillips, a director of Sera Prognostics, filed a Form 4 detailing changes in his beneficial ownership of the company's Class A Common Stock.
• The reported transactions involve distributions of shares from several Catalyst Health Ventures (CHV) funds to their limited partners on a pro rata basis, without consideration.
• These funds include Catalyst Health Ventures, L.P. (CHV LP), Catalyst Health Ventures (PF), L.P. (CHV PF), CHV Investments, LLC (CHV Investments), and Catalyst Health Ventures Follow-on Fund, L.P. (CHV FO).
• Phillips, as a managing member of CHV GP LLC and CHV I GP LLC (general partners of the CHV funds), and a limited partner in several of these funds, may be deemed to beneficially own the distributed shares.
• Phillips disclaims beneficial ownership of these securities except to the extent of his pecuniary benefit therein.
• The transactions occurred on June 3, 2024.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing (Form 4) detailing share distributions. It doesn't inherently convey positive or negative sentiment about the company's performance or future prospects.

Industry Context

Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company insiders. This filing reflects the distribution of shares from venture capital funds to their limited partners, which is a common practice.

Stakeholder Impact

• The share distribution may slightly alter the ownership structure of Sera Prognostics.
• The impact on shareholders is likely minimal, as the distributions are pro rata and do not represent a sale of shares on the open market.

Key Dates